Bibliografia UJ CM

1/3
Meredith M. Regan, Patrick Neven, Anita Giobbie-Hurder, Aron Goldhirsch, Bent Ejlertsen, Louis Mauriac, John F. Forbes, Ian Smith, Istvan Lang, Andrew Wardley, Manuela Rabaglio, Karen N. Price, Richard D. Gelber, Alan S. Coates, Beat Thurlimann, BIG 1-98 Collaborative Group, International Breast Cancer Study Group (IBCSG).
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8ˇ1 years median follow-up.
Lancet. Oncology
2011 : Vol. 12, nr 12, s. 1101-1108, il., bibliogr. 23 poz.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 22.589
2/3
Anita Giobbie-Hurder, Karen N. Price, Richard D. Gelber, International Breast Cancer Study Group (IBCSG), BIG 1-98 Collaborative Group.
Design, conduct, and analyses of Breast International Group (BIG) 1-98 : a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.
Clin. Trials (Lond. Print)
2009 : Vol. 6, nr 3, s. 272-286, il., bilbiogr. 14 poz.
p-ISSN: 1740-7745
AZ
ORG
AIF
IF: 1.917
3/3
BIG 1-98 Collaborative Group.
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
New England Journal of Medicine
2009 : Vol. 361, nr 8, s. 766-776, il., bibliogr. 29 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 47.050
Wyświetl ponownie stosując format: